APO Research
Talk to an analyst

APO RESEARCH · REPORT

Latanoprost

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Selected research

Industry Growth & Trends

Global Latanoprost Industry Growth and Trends Forecast to 2032

21 December 202599 pages

Choose your research edition.

Industry ResearchLatanoprost Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Latanoprost Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Latanoprost Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latanoprost Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Latanoprost Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Read the full market overview

Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.

Report Scope

This report provides a structured, data-driven view of the global Latanoprost market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Latanoprost market size, estimates, and forecasts are presented in terms of sales volume (M Unit) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Latanoprost market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Latanoprost.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Latanoprost market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Latanoprost Market by Company

Pfizer

Mylan

Novartis

Apotex

Teva

Taj Pharma

CR Zizhu

Latanoprost Segment by Type

Brand Drug

Generic Drug

Latanoprost Segment by Application

Open-angle Glaucoma

Close-angle Glaucoma

Latanoprost Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latanoprost and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Latanoprost manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Latanoprost in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Brand Drug Table 2. Major Company of Generic Drug Table 3. Global Latanoprost Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Latanoprost Sales by Type (2021-2026) & (M Unit) Table 5. Global Latanoprost Sales Market Share in Volume by Type (2021-2026) Table 6. Global Latanoprost Sales by Type (2021-2026) & (US$ Million) Table 7. Global Latanoprost Sales Market Share in Value by Type (2021-2026) Table 8. Global Latanoprost Price by Type (2021-2026) & (USD/Unit) Table 9. Global Latanoprost Sales by Type (2027-2032) & (M Unit) Table 10. Global Latanoprost Sales Market Share in Volume by Type (2027-2032) Table 11. Global Latanoprost Sales by Type (2027-2032) & (US$ Million) Table 12. Global Latanoprost Sales Market Share in Value by Type (2027-2032) Table 13. Global Latanoprost Price by Type (2027-2032) & (USD/Unit) Table 14. North America Latanoprost Sales by Type (2021-2026) & (M Unit) Table 15. North America Latanoprost Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Latanoprost Sales by Type (2021-2026) & (M Unit) Table 17. Europe Latanoprost Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Latanoprost Sales by Type (2021-2026) & (M Unit) Table 19. Asia-Pacific Latanoprost Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Latanoprost Sales by Type (2021-2026) & (M Unit) Table 21. Latin America Latanoprost Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Latanoprost Sales by Type (2021-2026) & (M Unit) Table 23. Middle East and Africa Latanoprost Sales by Type (2021-2026) & (US$ Million) Table 24. Latanoprost Industry Trends Table 25. Latanoprost Industry Drivers Table 26. Latanoprost Industry Opportunities and Challenges Table 27. Latanoprost Industry Restraints Table 28. Global Latanoprost Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Latanoprost Revenue Market Share by Company (2021-2026) Table 30. Global Latanoprost Sales by Company (2021-2026) & (M Unit) Table 31. Global Latanoprost Sales Share by Company (2021-2026) Table 32. Global Latanoprost Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Latanoprost Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Latanoprost Major Company Production Sites and Headquarters Table 35. Global Latanoprost Company, Product Type & Application Table 36. Global Latanoprost Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Latanoprost by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Latanoprost Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Latanoprost Sales by Region (2021-2026) & (M Unit) Table 41. Global Latanoprost Sales Market Share in Volume by Region (2021-2026) Table 42. Global Latanoprost Sales by Region (2021-2026) & (US$ Million) Table 43. Global Latanoprost Sales Market Share in Value by Region (2021-2026) Table 44. Global Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Latanoprost Sales by Region (2027-2032) & (M Unit) Table 46. Global Latanoprost Sales Market Share in Volume by Region (2027-2032) Table 47. Global Latanoprost Sales by Region (2027-2032) & (US$ Million) Table 48. Global Latanoprost Sales Market Share in Value by Region (2027-2032) Table 49. Global Latanoprost Sales (M Unit), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Latanoprost Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Latanoprost Sales by Application (2021-2026) & (M Unit) Table 52. Global Latanoprost Sales Market Share in Volume by Application (2021-2026) Table 53. Global Latanoprost Sales by Application (2021-2026) & (US$ Million) Table 54. Global Latanoprost Sales Market Share in Value by Application (2021-2026) Table 55. Global Latanoprost Price by Application (2021-2026) & (USD/Unit) Table 56. Global Latanoprost Sales by Application (2027-2032) & (M Unit) Table 57. Global Latanoprost Sales Market Share in Volume by Application (2027-2032) Table 58. Global Latanoprost Sales by Application (2027-2032) & (US$ Million) Table 59. Global Latanoprost Sales Market Share in Value by Application (2027-2032) Table 60. Global Latanoprost Price by Application (2027-2032) & (USD/Unit) Table 61. North America Latanoprost Sales by Application (2021-2026) & (M Unit) Table 62. North America Latanoprost Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Latanoprost Sales by Application (2021-2026) & (M Unit) Table 64. Europe Latanoprost Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Latanoprost Sales by Application (2021-2026) & (M Unit) Table 66. Asia-Pacific Latanoprost Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Latanoprost Sales by Application (2021-2026) & (M Unit) Table 68. Latin America Latanoprost Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Latanoprost Sales by Application (2021-2026) & (M Unit) Table 70. Middle East and Africa Latanoprost Sales by Application (2021-2026) & (US$ Million) Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Pfizer Latanoprost Product Portfolio Table 75. Pfizer Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Mylan Latanoprost Product Portfolio Table 80. Mylan Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Novartis Latanoprost Product Portfolio Table 85. Novartis Recent Development Table 86. Apotex Company Information Table 87. Apotex Business Overview Table 88. Apotex Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Apotex Latanoprost Product Portfolio Table 90. Apotex Recent Development Table 91. Teva Company Information Table 92. Teva Business Overview Table 93. Teva Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Teva Latanoprost Product Portfolio Table 95. Teva Recent Development Table 96. Taj Pharma Company Information Table 97. Taj Pharma Business Overview Table 98. Taj Pharma Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Taj Pharma Latanoprost Product Portfolio Table 100. Taj Pharma Recent Development Table 101. CR Zizhu Company Information Table 102. CR Zizhu Business Overview Table 103. CR Zizhu Latanoprost Sales (M Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. CR Zizhu Latanoprost Product Portfolio Table 105. CR Zizhu Recent Development Table 106. North America Latanoprost Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 107. North America Latanoprost Sales by Country (2021-2026) & (M Unit) Table 108. North America Latanoprost Sales Market Share by Country (2021-2026) Table 109. North America Latanoprost Sales Forecast by Country (2027-2032) & (M Unit) Table 110. North America Latanoprost Sales Market Share Forecast by Country (2027-2032) Table 111. North America Latanoprost Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Latanoprost Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Latanoprost Market Share by Country (2021-2026) Table 114. North America Latanoprost Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Latanoprost Market Share Forecast by Country (2027-2032) Table 116. Europe Latanoprost Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 117. Europe Latanoprost Sales by Country (2021-2026) & (M Unit) Table 118. Europe Latanoprost Sales Market Share by Country (2021-2026) Table 119. Europe Latanoprost Sales Forecast by Country (2027-2032) & (M Unit) Table 120. Europe Latanoprost Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Latanoprost Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Latanoprost Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Latanoprost Market Share by Country (2021-2026) Table 124. Europe Latanoprost Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Latanoprost Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Latanoprost Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Latanoprost Sales by Country (2021-2026) & (M Unit) Table 128. Asia-Pacific Latanoprost Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Latanoprost Sales Forecast by Country (2027-2032) & (M Unit) Table 130. Asia-Pacific Latanoprost Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Latanoprost Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Latanoprost Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Latanoprost Market Share by Country (2021-2026) Table 134. Asia-Pacific Latanoprost Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Latanoprost Market Share Forecast by Country (2027-2032) Table 136. Latin America Latanoprost Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 137. Latin America Latanoprost Sales by Country (2021-2026) & (M Unit) Table 138. Latin America Latanoprost Sales Market Share by Country (2021-2026) Table 139. Latin America Latanoprost Sales Forecast by Country (2027-2032) & (M Unit) Table 140. Latin America Latanoprost Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Latanoprost Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Latanoprost Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Latanoprost Market Share by Country (2021-2026) Table 144. Latin America Latanoprost Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Latanoprost Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Latanoprost Market Size Growth Rate (CAGR) by Country (M Unit): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Latanoprost Sales by Country (2021-2026) & (M Unit) Table 148. Middle East and Africa Latanoprost Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Latanoprost Sales Forecast by Country (2027-2032) & (M Unit) Table 150. Middle East and Africa Latanoprost Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Latanoprost Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Latanoprost Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Latanoprost Market Share by Country (2021-2026) Table 154. Middle East and Africa Latanoprost Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Latanoprost Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Latanoprost Distributors List Table 159. Latanoprost Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Latanoprost Image Figure 2. Global Latanoprost Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Latanoprost Market Size (2021-2032) & (US$ Million) Figure 4. Global Latanoprost Sales (2021-2032) & (M Unit) Figure 5. Brand Drug Image Figure 6. Global Brand Drug Sales YoY Growth (2021-2032) & (M Unit) Figure 7. Generic Drug Image Figure 8. Global Generic Drug Sales YoY Growth (2021-2032) & (M Unit) Figure 9. Global Latanoprost Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Latanoprost Market Share by Type 2025 VS 2032 Figure 11. North America Latanoprost Sales Market Share in Volume by Type in 2025 Figure 12. North America Latanoprost Sales Market Share in Value by Type in 2025 Figure 13. Europe Latanoprost Sales Market Share in Volume by Type in 2025 Figure 14. Europe Latanoprost Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Latanoprost Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Latanoprost Sales Market Share in Value by Type in 2025 Figure 17. Latin America Latanoprost Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Latanoprost Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Latanoprost Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Latanoprost Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Latanoprost Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Open-angle Glaucoma Image Figure 24. Global Open-angle Glaucoma Sales YoY Growth (2021-2032) & (M Unit) Figure 25. Close-angle Glaucoma Image Figure 26. Global Close-angle Glaucoma Sales YoY Growth (2021-2032) & (M Unit) Figure 27. Global Latanoprost Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Latanoprost Market Share by Application 2025 VS 2032 Figure 29. North America Latanoprost Sales Market Share in Volume by Application in 2025 Figure 30. North America Latanoprost Sales Market Share in Value by Application in 2025 Figure 31. Europe Latanoprost Sales Market Share in Volume by Application in 2025 Figure 32. Europe Latanoprost Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Latanoprost Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Latanoprost Sales Market Share in Value by Application in 2025 Figure 35. Latin America Latanoprost Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Latanoprost Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Latanoprost Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Latanoprost Sales Market Share in Value by Application in 2025 Figure 39. North America Latanoprost Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 40. North America Latanoprost Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Latanoprost Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Latanoprost Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Latanoprost Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 44. Europe Latanoprost Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Latanoprost Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Latanoprost Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Latanoprost Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 48. Asia-Pacific Latanoprost Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Latanoprost Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Latanoprost Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Latanoprost Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 52. Latin America Latanoprost Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Latanoprost Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Latanoprost Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Latanoprost Sales by Country: 2021 VS 2025 VS 2032 (M Unit) Figure 56. Middle East and Africa Latanoprost Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Latanoprost Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Latanoprost Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latanoprost Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Latanoprost Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drug
  • Generic Drug
Applications
  • Open-angle Glaucoma
  • Close-angle Glaucoma
Companies covered
  • Pfizer
  • Mylan
  • Novartis
  • Apotex
  • Teva
  • Taj Pharma
  • CR Zizhu

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Latanoprost Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Latanoprost Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Latanoprost Market by Type
  6. 1.3.1 Brand Drug
  7. 1.3.2 Generic Drug
  8. 1.4 Global Latanoprost Market Size by Type
  9. 1.4.1 Global Latanoprost Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Latanoprost Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Latanoprost Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Latanoprost Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Latanoprost Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Latanoprost Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Latanoprost Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Latanoprost Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Latanoprost Industry Trends
  2. 2.2 Latanoprost Industry Drivers
  3. 2.3 Latanoprost Industry Opportunities and Challenges
  4. 2.4 Latanoprost Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Latanoprost Revenue (2021-2026)
  2. 3.2 Global Top Players by Latanoprost Sales (2021-2026)
  3. 3.3 Global Top Players by Latanoprost Price (2021-2026)
  4. 3.4 Global Latanoprost Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Latanoprost Major Company Production Sites & Headquarters
  6. 3.6 Global Latanoprost Company, Product Type & Application
  7. 3.7 Global Latanoprost Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Latanoprost Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Latanoprost Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Latanoprost Tier 1, Tier 2, and Tier 3
4 Latanoprost Regional Status and Outlook
  1. 4.1 Global Latanoprost Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Latanoprost Historic Market Size by Region
  3. 4.2.1 Global Latanoprost Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Latanoprost Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Latanoprost Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Latanoprost Forecasted Market Size by Region
  7. 4.3.1 Global Latanoprost Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Latanoprost Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Latanoprost Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Latanoprost by Application
  1. 5.1 Latanoprost Market by Application
  2. 5.1.1 Open-angle Glaucoma
  3. 5.1.2 Close-angle Glaucoma
  4. 5.2 Global Latanoprost Market Size by Application
  5. 5.2.1 Global Latanoprost Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Latanoprost Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Latanoprost Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Latanoprost Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Latanoprost Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Latanoprost Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Latanoprost Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Latanoprost Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Latanoprost Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Latanoprost Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Latanoprost Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Latanoprost Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Latanoprost Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Latanoprost Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Apotex
  20. 6.4.1 Apotex Company Information
  21. 6.4.2 Apotex Business Overview
  22. 6.4.3 Apotex Latanoprost Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Apotex Latanoprost Product Portfolio
  24. 6.4.5 Apotex Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva Latanoprost Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Latanoprost Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 Taj Pharma
  32. 6.6.1 Taj Pharma Company Information
  33. 6.6.2 Taj Pharma Business Overview
  34. 6.6.3 Taj Pharma Latanoprost Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Taj Pharma Latanoprost Product Portfolio
  36. 6.6.5 Taj Pharma Recent Developments
  37. 6.7 CR Zizhu
  38. 6.7.1 CR Zizhu Company Information
  39. 6.7.2 CR Zizhu Business Overview
  40. 6.7.3 CR Zizhu Latanoprost Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CR Zizhu Latanoprost Product Portfolio
  42. 6.7.5 CR Zizhu Recent Developments
7 North America by Country
  1. 7.1 North America Latanoprost Sales by Country
  2. 7.1.1 North America Latanoprost Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Latanoprost Sales by Country (2021-2026)
  4. 7.1.3 North America Latanoprost Sales Forecast by Country (2027-2032)
  5. 7.2 North America Latanoprost Market Size by Country
  6. 7.2.1 North America Latanoprost Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Latanoprost Market Size by Country (2021-2026)
  8. 7.2.3 North America Latanoprost Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Latanoprost Sales by Country
  2. 8.1.1 Europe Latanoprost Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Latanoprost Sales by Country (2021-2026)
  4. 8.1.3 Europe Latanoprost Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Latanoprost Market Size by Country
  6. 8.2.1 Europe Latanoprost Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Latanoprost Market Size by Country (2021-2026)
  8. 8.2.3 Europe Latanoprost Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Latanoprost Sales by Country
  2. 9.1.1 Asia-Pacific Latanoprost Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Latanoprost Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Latanoprost Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Latanoprost Market Size by Country
  6. 9.2.1 Asia-Pacific Latanoprost Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Latanoprost Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Latanoprost Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Latanoprost Sales by Country
  2. 10.1.1 South America Latanoprost Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Latanoprost Sales by Country (2021-2026)
  4. 10.1.3 South America Latanoprost Sales Forecast by Country (2027-2032)
  5. 10.2 South America Latanoprost Market Size by Country
  6. 10.2.1 South America Latanoprost Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Latanoprost Market Size by Country (2021-2026)
  8. 10.2.3 South America Latanoprost Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Latanoprost Sales by Country
  2. 11.1.1 Middle East and Africa Latanoprost Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Latanoprost Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Latanoprost Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Latanoprost Market Size by Country
  6. 11.2.1 Middle East and Africa Latanoprost Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Latanoprost Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Latanoprost Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Latanoprost Value Chain Analysis
  2. 12.1.1 Latanoprost Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Latanoprost Production Mode & Process
  7. 12.2 Latanoprost Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Latanoprost Distributors
  10. 12.2.3 Latanoprost Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst